UPDATE: Abbott closes $410 million Evalve buy September 10, 2009 By MassDevice staff Filed Under: Business/Financial News More recent news Edwards Lifesciences beats the Street in Q1 and increases sales outlook Dexcom stock slides despite Q1 beats, sales guidance increase ResMed sees increased sleep device demand, stock rises on Q3 beats